-
If you purchased shares of Osiris Therapeutics Inc (NASDAQ: OSIR), you might have certain options and should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
February 4, 2019 - Order Granting Final Approval of Class Action Settlement and Entering Final Judgment and Order of Dismissal with Prejudice. September 4, 2018 - The court preliminarily approved the settlement. June 12, 2018 - Parties filed a stipulation of settlement. April 6, 2018 - The lead plaintiff filed an amended complaint on behalf of investors who purchased Osiris Therap...
You must register (for free) or login to view the entire case.
